Results 141 to 150 of about 48,162 (201)

The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC. [PDF]

Nat Commun
Richard J, Grunst MW, Niu L, Díaz-Salinas MA, Zhu L, Tolbert WD, Marchitto L, Zhou F, Bourassa C, Kim H, Boodapati SLT, Yang D, Chiu TJ, Chen HC, Benlarbi M, Beaudoin-Bussières G, Gottumukkala S, Li W, Dionne K, Bélanger É, Chatterjee D, Medjahed H, Hendrickson WA, Sodroski J, Lang ZC, Morton AJ, Huang RK, Matthies D, Smith AB, Kumar P, Mothes W, Munro JB, Pazgier M, Finzi A.   +33 more
europepmc   +1 more source

Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection. [PDF]

Front Immunol
Grunst MW, Li W, Mothes W.
europepmc   +1 more source

HIV subtype-specific gp140-CD4 binding, Temsavir efficacy, and identification of novel adhesion inhibitors against Chinese HIV strains. [PDF]

Front Immunol
Liu T, Li X, Yang X, Zhang S, Wang Y, Zhang S, Cheng L, Tang S, Wang F, Zhao Y, Lu H, Wei L.   +11 more
europepmc   +1 more source

Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptase. [PDF]

PLoS Pathog
Aldunate M, Tyssen D, Johnson A, Latham CF, Ellenberg P, Cowieson N, Hayward JA, Center RJ, Ramsland PA, Hearps AC, Tachedjian G.   +10 more
europepmc   +1 more source

Roles of Reactive Oxygen Species in Relationships Between Viral Infections and Alzheimer's Disease and Related Dementia. [PDF]

Antioxidants (Basel)
Ayyubova G, Bablu FE, Rahimli N, Aghayeva L, Springer EM, Alghenaim FA, Suzuki YJ.   +6 more
europepmc   +1 more source

Design of a highly potent bifunctional HIV-1 entry inhibitor targeting both gp120 and gp41. [PDF]

RSC Med Chem
Du X, Li Q, Du S, Wang H, Shi A, Yuan M, Yu F, Liu Y, Wang C.   +8 more
europepmc   +1 more source

Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1. [PDF]

Sci Rep
Klingler J, Rao PG, Bandres JC, Pena I, Roldan KB, Singh G, Monahan B, Gleason C, Chen Y, Slamanig S, Sun W, Upadhyay C, Hioe CE.   +12 more
europepmc   +1 more source

HIV Envelope Protein gp120 [PDF]

, 2020
openaire   +1 more source

Understanding the performance of HIV-1 viral vector vaccines: adenovirus and poxvirus case studies. [PDF]

Front Immunol
Manafi MM, Farzani T, Espinoza N, Ozonoff A, Sabeti PC.   +4 more
europepmc   +1 more source

Multi-attribute monitoring (MAM) methodology for glycosylated subunit vaccines. [PDF]

Sci Rep
Shajahan A, Jenkins LM, Barefoot N, Maldonado D, Wolff JJ, Yang Y, Kueltzo LA, Ficca V, Scheideman E, Loukinov I, Carruthers C, Benmohamed D, Gowetski DB, Jiang R, Yang SR, Carlton K, Gall JG, Lei QP.   +17 more
europepmc   +1 more source